Sarepta Therapeutics falls sharply after suspending shipments of Elevidys for infusions in non-ambulatory patients because of the death of a second patient from acute liver failure.

President Trump on Friday cleared the way for Japan-based Nippon Steel to potentially acquire U.S. Steel, though details about the structure of the deal — including a possible "golden share" held by the federal government — remain unclear.

Sarepta Therapeutics shares plunged 36% after the company reported a second case of acute liver failure resulting in death from taking Elevidys, which is a gene therapy for patients with Duchenne muscular dystrophy.

The Japanese company has already committed to heavy investment in U.S. Steel and a U.S.-controlled board of directors at the American steelmaker.

China churned out a lot less steel in May compared to the previous year as mills responded to the government’s pledge to cut production.

WASHINGTON (AP) — President Donald Trump on Friday signed an executive order paving the way for a Nippon Steel investment in U.S. Steel, so long as the Japanese company complies with a “national security agreement” submitted by the federal government. Trump’s order didn’t detail the terms of the national security agreement.

The Trump administration will soon ensure that its 50% steel tariffs, which have threatened to make everything containing steel more expensive, will apply to your next fridge or dishwasher.

The first concern will be financing, necessary to fund both the all-cash acquisition and the promised investments, which range from upgrades to existing plants to a new steel mill